![Youssef Bennani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Youssef Bennani
Directeur Général chez
Find Therapeutics
Profil
Youssef L.
Bennani is currently Chief Executive Officer at Neurasic Therapeutics, Inc., Chairman at Domain Therapeutics SA since 2014, Director at Find Therapeutics, Inc. since 2022, Member at the Institute of Corporate Directors, Chief Scientific Officer at adMare Bioinnovations, and Managing Partner at both CTI Life Sciences Fund and CTI Capital, Inc. since 2021.
Former roles include Chairman at Domain Therapeutics SA from 2014 to 2024, Independent Director at BELLUS Health, Inc. from 2017 to 2023, Vice President-Drug Innovation at Vertex Pharmaceuticals, Inc., Principal at Ligand Pharmaceuticals, Inc., AbbVie, Inc., and Athersys, Inc., Member at Neomed Institute, and Vice President-Research & Development, Site Head at Vertex Pharmaceuticals (Canada), Inc. from 2013 to 2017.
Education includes graduate studies at The Scripps Research Institute, undergraduate and doctorate degrees from the University of Montréal, and an MBA from Lake Forest Graduate School of Management conferred in 2000.
Postes actifs de Youssef Bennani
| Sociétés | Poste | Début |
|---|---|---|
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Président | 01/04/2014 |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Find Therapeutics
 Find Therapeutics BiotechnologyHealth Technology Engages in research & development of therapeutics for inflammatory and fibrotic diseases | Directeur Général | - |
adMare Bioinnovations
 adMare Bioinnovations Miscellaneous Commercial ServicesCommercial Services adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | - |
Neurasic Therapeutics, Inc.
 Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops opiate-sparing and pain-relieving drugs | Directeur Général | - |
CTI Life Sciences Fund
 CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services Provides life science related services | Corporate Officer/Principal | 01/05/2021 |
CTI Capital, Inc.
 CTI Capital, Inc. Investment ManagersFinance CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins. | Private Equity Investor | 01/05/2021 |
Anciens postes connus de Youssef Bennani
| Sociétés | Poste | Fin |
|---|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Président | 08/01/2024 |
| BELLUS HEALTH | Directeur/Membre du Conseil | 01/06/2023 |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Youssef Bennani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
CTI Capital, Inc.
CTI Capital, Inc. Investment ManagersFinance CTI Capital Inc. offers debt and equity trading, portfolio management, research, retail brokerage and investment banking services. They specialize in initial public offerings and new issues, private placements, reverse takeovers, capital pool companies, mergers and acquisitions and exchange sponsorships for emerging growth-oriented companies. The firm's equity research focuses on continuous global monitoring of the Canadian stock market. Their strategies are based on the evaluation of economic, financial and technical data. The firm employs market call systems that are based on fundamental and technical factors. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. The CTI Sciences Fund is a venture capital fund that invests primarily in companies located in Quebec and Canada. The Fund focuses on investments in biotechnological or biopharmaceutical products and medical devices. The financial partners of this private venture are the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, FIER Partenaires S.E.C. and the Régime des rentes du Mouvement Desjardins. | Finance |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Health Technology |
Institute of Corporate Directors
Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Lake Forest Graduate School of Management
 Lake Forest Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neomed Institute
 Neomed Institute Pharmaceuticals: OtherHealth Technology Operates as a non-profit organization for pharmaceutical companies | Health Technology |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Commercial Services |
adMare Bioinnovations
adMare Bioinnovations Miscellaneous Commercial ServicesCommercial Services adMare Bioinnovations engages in the provision of research for its academic and biotech partners. The company was founded in 2011 and is headquartered in Vancouver, Canada. | Commercial Services |
Neurasic Therapeutics, Inc.
Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops opiate-sparing and pain-relieving drugs | Health Technology |
Find Therapeutics
Find Therapeutics BiotechnologyHealth Technology Engages in research & development of therapeutics for inflammatory and fibrotic diseases | Health Technology |
CTI Life Sciences Fund
CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services Provides life science related services | Commercial Services |
